drugset / Trial / NCT07395687

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

NCT07395687

Phase 2 Recruiting 333 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.

Timeline

Start
2026-02-02
Primary completion
2027-01-14
Completion
2027-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject UBT251 Unknown Subcutaneous

Indications